Skip to main content

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

GYRE holding history

Gyre Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GYRE overviewAll 13F holders of GYREFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q1 2025
Holdings of GYRE by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−98−100.0%Sold outHolders
Q1 202698$683<0.1%+98NewHolders
Q2 20250$00.0%−17−100.0%Sold outHolders
Q1 202517$131<0.1%+17NewHolders